Medicenna Therapeutics Corp Cash Flow Quality Index
Medicenna Therapeutics Corp cash flow quality index. Medicenna Therapeutics Corp (MDNA) has a Cash Flow Quality Index of -4.21x as of March 2025. Operating cash flow of CA$-5.00 Million is below net income of CA$1.19 Million, suggesting accrual-heavy earnings not yet converted to cash. See Medicenna Therapeutics Corp (MDNA) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medicenna Therapeutics Corp Cash Flow Quality Index by Year (None–None)
Medicenna Therapeutics Corp cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Medicenna Therapeutics Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Medicenna Therapeutics Corp.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|